InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Tilton John, Dirigeant. Director active across 1 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 4 reports have been published. The latest transaction was disclosed on 6 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
01,250 shares0
Common Shares
SEC:0001562180-22-000357·
01,250 shares0
Common Shares
SEC:0001562180-22-000357:0·
01,250 shares0
Common Shares
SEC:0001562180-21-007304·
01,250 shares0
Common Shares
SEC:0001562180-21-007304:0·
4 of 4 declarations
About Tilton John
John Tilton is the Chief Commercial Officer at Biohaven Pharmaceutical Holding Co Ltd. He oversees the company's business strategies, which focus on developing innovative treatments. Biohaven is recognized for its commitment to innovation in the pharmaceutical sector. John's experience is crucial for the company's growth.
